JP7480485B2 - Cell Isolation Methods - Google Patents
Cell Isolation Methods Download PDFInfo
- Publication number
- JP7480485B2 JP7480485B2 JP2019181181A JP2019181181A JP7480485B2 JP 7480485 B2 JP7480485 B2 JP 7480485B2 JP 2019181181 A JP2019181181 A JP 2019181181A JP 2019181181 A JP2019181181 A JP 2019181181A JP 7480485 B2 JP7480485 B2 JP 7480485B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- block copolymer
- cell
- lcst
- cell culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002955 isolation Methods 0.000 title description 2
- 210000004027 cell Anatomy 0.000 claims description 160
- 229920001400 block copolymer Polymers 0.000 claims description 55
- 238000004113 cell culture Methods 0.000 claims description 36
- 239000000758 substrate Substances 0.000 claims description 19
- 239000011248 coating agent Substances 0.000 claims description 12
- 238000000576 coating method Methods 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 9
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 9
- 238000003320 cell separation method Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000011557 critical solution Substances 0.000 claims description 5
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical group CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 claims description 5
- 238000010899 nucleation Methods 0.000 claims description 5
- 210000001185 bone marrow Anatomy 0.000 claims description 3
- 201000010897 colon adenocarcinoma Diseases 0.000 claims description 3
- 208000029742 colonic neoplasm Diseases 0.000 claims description 3
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical group COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 claims description 2
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical group CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims description 2
- 210000003074 dental pulp Anatomy 0.000 claims description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 2
- 239000002609 medium Substances 0.000 description 33
- 239000006285 cell suspension Substances 0.000 description 15
- 230000001464 adherent effect Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
- 239000012091 fetal bovine serum Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 239000007640 basal medium Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000007758 minimum essential medium Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- IPJDHSYCSQAODE-UHFFFAOYSA-N 5-chloromethylfluorescein diacetate Chemical compound O1C(=O)C2=CC(CCl)=CC=C2C21C1=CC=C(OC(C)=O)C=C1OC1=CC(OC(=O)C)=CC=C21 IPJDHSYCSQAODE-UHFFFAOYSA-N 0.000 description 5
- 230000001747 exhibiting effect Effects 0.000 description 5
- 210000002744 extracellular matrix Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 102000018697 Membrane Proteins Human genes 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- CCIDRBFZPRURMU-UHFFFAOYSA-N 2-methyl-n-propylprop-2-enamide Chemical compound CCCNC(=O)C(C)=C CCIDRBFZPRURMU-UHFFFAOYSA-N 0.000 description 2
- VIEYMVWPECAOCY-UHFFFAOYSA-N 7-amino-4-(chloromethyl)chromen-2-one Chemical compound ClCC1=CC(=O)OC2=CC(N)=CC=C21 VIEYMVWPECAOCY-UHFFFAOYSA-N 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- 102000007547 Laminin Human genes 0.000 description 2
- 102100037369 Nidogen-1 Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- -1 methacryloyl group Chemical group 0.000 description 2
- 108010008217 nidogen Proteins 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000001226 reprecipitation Methods 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- JJOYJOCWEDSDOO-UHFFFAOYSA-N 2-methyl-n-(oxolan-2-ylmethyl)prop-2-enamide Chemical compound CC(=C)C(=O)NCC1CCCO1 JJOYJOCWEDSDOO-UHFFFAOYSA-N 0.000 description 1
- YQIGLEFUZMIVHU-UHFFFAOYSA-N 2-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C(C)=C YQIGLEFUZMIVHU-UHFFFAOYSA-N 0.000 description 1
- UNYMAOKXTDZXGI-UHFFFAOYSA-N C(OCC#N)(OCCCCCCCCCCCC)=O Chemical compound C(OCC#N)(OCCCCCCCCCCCC)=O UNYMAOKXTDZXGI-UHFFFAOYSA-N 0.000 description 1
- 108091016585 CD44 antigen Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 102000008055 Heparan Sulfate Proteoglycans Human genes 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108090000054 Syndecan-2 Proteins 0.000 description 1
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 description 1
- YLQHOUDDHYMERA-UHFFFAOYSA-N n-(2-ethoxyethyl)prop-2-enamide Chemical compound CCOCCNC(=O)C=C YLQHOUDDHYMERA-UHFFFAOYSA-N 0.000 description 1
- KPEKHIHQXHOSRM-UHFFFAOYSA-N n-(oxolan-2-ylmethyl)prop-2-enamide Chemical compound C=CC(=O)NCC1CCCO1 KPEKHIHQXHOSRM-UHFFFAOYSA-N 0.000 description 1
- FIBUWQFQYAAXHD-UHFFFAOYSA-N n-cyclopropyl-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1CC1 FIBUWQFQYAAXHD-UHFFFAOYSA-N 0.000 description 1
- LCXIFAOALNZGDO-UHFFFAOYSA-N n-cyclopropylprop-2-enamide Chemical compound C=CC(=O)NC1CC1 LCXIFAOALNZGDO-UHFFFAOYSA-N 0.000 description 1
- ZOTWHNWBICCBPC-UHFFFAOYSA-N n-ethyl-n-methylprop-2-enamide Chemical compound CCN(C)C(=O)C=C ZOTWHNWBICCBPC-UHFFFAOYSA-N 0.000 description 1
- SWPMNMYLORDLJE-UHFFFAOYSA-N n-ethylprop-2-enamide Chemical compound CCNC(=O)C=C SWPMNMYLORDLJE-UHFFFAOYSA-N 0.000 description 1
- COYVWKMZTCAFHO-UHFFFAOYSA-N n-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)N(C)C(=O)C=C COYVWKMZTCAFHO-UHFFFAOYSA-N 0.000 description 1
- RGNKVBUBMHKKJP-UHFFFAOYSA-N n-methyl-n-propylprop-2-enamide Chemical compound CCCN(C)C(=O)C=C RGNKVBUBMHKKJP-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- UYCAUPASBSROMS-AWQJXPNKSA-M sodium;2,2,2-trifluoroacetate Chemical compound [Na+].[O-][13C](=O)[13C](F)(F)F UYCAUPASBSROMS-AWQJXPNKSA-M 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明は、細胞分離方法に関する。 The present invention relates to a cell separation method.
再生医療やテーラーメード治療などの被検体由来の細胞が必要な分野において、目的細胞を効率よく分離・検出・培養する技術が必要とされる。これまでに目的細胞を分離する方法として、蛍光標識された抗体を目的細胞の表面タンパク質に修飾して分離するフローサイトメトリーや、磁気標識された抗体を目的細胞の表面タンパク質に修飾して外部磁場で分離する磁気細胞分離法など、イムノアフィニティに関する技術が主流である。しかし、使用する抗体などの試薬が高価であり、ランニングコストが高いという課題がある。また、イムノアフィニティ技術は細胞の表面タンパク質に抗体を修飾することで細胞にダメージを与えてしまう課題もある。将来的な再生医療分野等の発展のためには、安価に目的細胞を低侵襲で分離できる細胞分離技術が求められる。 In fields such as regenerative medicine and tailored treatments that require cells derived from specimens, there is a need for technology to efficiently separate, detect, and culture target cells. To date, the mainstream methods for separating target cells have been immunoaffinity-related technologies, such as flow cytometry, in which fluorescently labeled antibodies are attached to the surface proteins of target cells and then separated, and magnetic cell separation, in which magnetically labeled antibodies are attached to the surface proteins of target cells and then separated using an external magnetic field. However, there are issues with the high running costs, as the reagents used, such as antibodies, are expensive. In addition, immunoaffinity technology has the issue that it can damage cells by attaching antibodies to the surface proteins of cells. For the future development of fields such as regenerative medicine, there is a need for cell separation technology that can separate target cells inexpensively and minimally invasively.
本発明の目的は、目的細胞を低侵襲で分離できる細胞分離方法を提供することにある。 The object of the present invention is to provide a cell separation method that can separate target cells in a minimally invasive manner.
本発明者らは、以上の点を鑑み、鋭意研究を重ねた結果、本発明を完成した。 In light of the above, the inventors conducted extensive research and completed the present invention.
すなわち本発明の一態様は、下限臨界溶解温度(LCST)を示すセグメントを含むブロック共重合体を被覆した細胞培養器材に2種類以上の細胞を播種する工程と、前記細胞培養器材から前記ブロック共重合体に非接着の細胞を除く工程と、前記細胞培養器材をLCST以下に冷却して前記ブロック共重合体に接着した細胞を回収する工程と、を含んでなることを特徴とする細胞分離方法である。 That is, one aspect of the present invention is a cell separation method comprising the steps of seeding two or more types of cells on a cell culture vessel coated with a block copolymer containing a segment exhibiting a lower critical solution temperature (LCST), removing cells that do not adhere to the block copolymer from the cell culture vessel, and cooling the cell culture vessel to a temperature below the LCST to recover the cells that have adhered to the block copolymer.
本発明により、安価に目的細胞を低侵襲で分離できる。 This invention allows for inexpensive, minimally invasive isolation of target cells.
以下、本発明の一態様について詳細に説明するが、本発明を以下の内容に限定する趣旨ではない。本発明は、その趣旨の範囲内で適宜に変形して実施できる。 One aspect of the present invention is described in detail below, but the present invention is not limited to the following content. The present invention can be modified as appropriate within the scope of its intent.
LCSTとは下限臨界溶解温度(Lower Critical Solution Temperature:LCST)であり、この温度よりも低い温度では高分子が水に溶解して透明の溶液になるが、この温度よりも高い温度では不溶化して白濁するか沈殿が生じ、相分離する温度である。 LCST stands for Lower Critical Solution Temperature (LCST), below which the polymer dissolves in water to form a transparent solution, but above which it becomes insoluble and either becomes cloudy or precipitates, resulting in phase separation.
ブロック共重合体は、2種類以上の繰り返し単位からなる重合体で、それぞれ同種の繰り返し単位からなる高分子鎖が、1本の鎖の中に結合している重合体をいう。 A block copolymer is a polymer consisting of two or more types of repeating units, in which polymer chains consisting of the same type of repeating units are bonded together in a single chain.
下限臨界溶解温度(LCST)を示すセグメントを含むブロック共重合体は、特に限定はないが、重合が容易なことから、アクリロイル基あるいはメタクリロイル基を含む構造であることが好ましい。下限臨界溶解温度(LCST)を示すセグメントの繰返し単位(以下、「LCST繰返し単位」ということがある)とその水に対するLCSTは、例えば、N-エチルアクリルアミド(LCST=72℃)、N-シクロプロピルアクリルアミド(LCST=46℃)、N-イソプロピルアクリルアミド(LCST=32℃)、N-n-プロピルメタクリルアミド(LCST=22℃)、N-テトラヒドロフルフリルアクリルアミド(LCST=28℃)、N-エトキシエチルアクリルアミド(LCST=35℃)、N,N-ジエチルアクリルアミド(LCST=32℃)、N-シクロプロピルメタクリルアミド(LCST=59℃)、N-イソプロピルメタクリルアミド(LCST=44℃)、N-n-プロピルメタクリルアミド(LCST=28℃)、N-テトラヒドロフルフリルメタクリルアミド(LCST=35℃)、N-メチル-N-エチルアクリルアミド(LCST=56℃)、N-メチル-N-イソプロピルアクリルアミド(LCST=23℃)、N-メチル-N-n-プロピルアクリルアミド(LCST=20℃)、またはN,N-ジメチルアミノエチルメタクリレート(LCST=47℃)等が例示できる。LCSTの上限は、細胞培養温度は一般的に高温ではタンパク質変性に伴う細胞へのダメージが発生することから42℃が好ましく、40℃がより好ましい。また、LCSTの下限は、低温での細胞活性の低下を避ける為に、10℃が好ましく、20℃がより好ましい。LCST繰返し単位としては、その繰り返し単位を1種類のみ用いてもよく、2種類以上を組み合わせて用いてもよい。また、ブロック共重合体が温度変化によって親水性/疎水性の程度が変化する性質(以下、「温度応答性」ということがある)を有するのであれば、LCST繰返し単位の他に、異なる繰返し単位を含んでも良い。 There are no particular limitations on the block copolymer containing a segment exhibiting a lower critical solution temperature (LCST), but it is preferable that the block copolymer has a structure containing an acryloyl group or a methacryloyl group, since this facilitates polymerization. The repeating unit of the segment exhibiting a lower critical solution temperature (LCST) (hereinafter sometimes referred to as the "LCST repeating unit") and its LCST with respect to water are, for example, N-ethylacrylamide (LCST = 72°C), N-cyclopropylacrylamide (LCST = 46°C), N-isopropylacrylamide (LCST = 32°C), N-n-propylmethacrylamide (LCST = 22°C), N-tetrahydrofurfuryl acrylamide (LCST = 28°C), N-ethoxyethylacrylamide (LCST = 35°C), N,N-diethylacrylamide (LCST = 3 2°C), N-cyclopropyl methacrylamide (LCST = 59°C), N-isopropyl methacrylamide (LCST = 44°C), N-n-propyl methacrylamide (LCST = 28°C), N-tetrahydrofurfuryl methacrylamide (LCST = 35°C), N-methyl-N-ethylacrylamide (LCST = 56°C), N-methyl-N-isopropylacrylamide (LCST = 23°C), N-methyl-N-n-propylacrylamide (LCST = 20°C), or N,N-dimethylaminoethyl methacrylate (LCST = 47°C) can be exemplified. The upper limit of the LCST is preferably 42°C, more preferably 40°C, because cell culture temperatures generally cause damage to cells due to protein denaturation at high temperatures. The lower limit of the LCST is preferably 10°C, more preferably 20°C, in order to avoid a decrease in cell activity at low temperatures. As the LCST repeating unit, only one type of repeating unit may be used, or two or more types may be used in combination. Furthermore, if the block copolymer has the property that the degree of hydrophilicity/hydrophobicity changes with temperature (hereinafter, sometimes referred to as "temperature responsiveness"), it may contain a different repeat unit in addition to the LCST repeat unit.
ブロック共重合体を構成するセグメントの数は2以上であればよく、3以上であっても構わない。ブロック共重合体中のLCST繰返し単位の構成割合は、5~95mol%であることが好ましく、30~90mol%であることがより好ましく、40~80mol%であることがさらに好ましい。ブロック共重合体を構成するセグメントには、温度応答性及び細胞培養器材への被覆性を向上させるために、LCSTを示すセグメントのほかに、0℃~50℃の範囲にLCSTを持たない、HLB値(グリフィン法)が9以上20以下の範囲にある親水性重合体セグメントと、0℃~50℃の範囲にLCSTを持たない、HLB値(グリフィン法)が0以上9未満の範囲にある疎水性重合体セグメントをさらに含んでいることが好ましい。これらのセグメントは、特開2018-087316号公報に記載されたセグメントを用いることができる。 The number of segments constituting the block copolymer may be 2 or more, and may be 3 or more. The composition ratio of the LCST repeating unit in the block copolymer is preferably 5 to 95 mol%, more preferably 30 to 90 mol%, and even more preferably 40 to 80 mol%. In order to improve temperature responsiveness and coverage of cell culture substrates, the segments constituting the block copolymer preferably further contain, in addition to the segment exhibiting LCST, a hydrophilic polymer segment having no LCST in the range of 0°C to 50°C and an HLB value (Griffin method) in the range of 9 to 20, and a hydrophobic polymer segment having no LCST in the range of 0°C to 50°C and an HLB value (Griffin method) in the range of 0 to less than 9. For these segments, the segments described in JP 2018-087316 A can be used.
細胞培養器材へのブロック共重合体の被覆方法として特に限定はないが、例えば特開2018-087316号公報に記載された定法を用いることができる。ブロック共重合体のLCSTを示すセグメントの被覆量は、0.1μg/cm2以上20.0μg/cm2以下の割合で被覆されることが好ましく、0.2μg/cm2以上10.0μg/cm2以下の割合で被覆されることがより好ましい。被覆量の測定は定法に従えばよく、例えば、天秤を用いた秤量を利用すればよい。なお、細胞培養器材の形状としては、ディッシュ、プレート又はフラスコが例示できる。 There is no particular limitation on the method of coating the cell culture equipment with the block copolymer, but for example, the standard method described in JP 2018-087316 A can be used. The amount of coating of the segment exhibiting the LCST of the block copolymer is preferably 0.1 μg/cm 2 or more and 20.0 μg/cm 2 or less, and more preferably 0.2 μg/cm 2 or more and 10.0 μg/cm 2 or less. The amount of coating can be measured according to a standard method, for example, by weighing using a balance. Examples of the shape of the cell culture equipment include a dish, a plate, and a flask.
細胞培養用器材には、ブロック共重合体の表面にさらに細胞外マトリックスを被覆してもよい。細胞外マトリックスの種類は特に限定は無く、例えば、コラーゲン、アテロコラーゲン、ヒアルロン酸、エラスチン、プロテオグリカン、グルコサミノグリカン、フィブロネクチン、ラミニン、ビトロネクチン、ゼラチン、ラミニン、コラーゲンIV、ヘパラン硫酸プロテオグリカン、エンタクチン/ナイドジェン1,2等を主成分として含有するマトリゲルを用いてもよく、これらを一種又は二種以上用いてもよい。また、これら細胞外マトリックスのセグメントであってもよい。 In the cell culture equipment, the surface of the block copolymer may be further coated with an extracellular matrix. There are no particular limitations on the type of extracellular matrix, and for example, Matrigel containing collagen, atelocollagen, hyaluronic acid, elastin, proteoglycan, glycosaminoglycan, fibronectin, laminin, vitronectin, gelatin, laminin, collagen IV, heparan sulfate proteoglycan, entactin/nidogen 1, 2, etc. as the main component may be used, or one or more of these may be used. Also, it may be a segment of these extracellular matrices.
細胞の種類(以下、「細胞種」ということがある)は2種類以上であれば特に限定はなく、3種類以上であってもよい。用いる細胞種の組合せは特に限定はないが、線維芽細胞及び/又は上皮細胞は好適に本発明に用いられる。それ以外にも、血球系細胞、神経系や内臓系を構築する細胞といった異種細胞種が混合した状態や、間葉系幹細胞などの分化能を有した細胞の分化状態が異なる状態に対しても本発明を用いることは可能であるが、接着細胞であることが好ましい。また、ヒト以外の細胞であってもよく、例えば、マウスやハムスター、ウサギやサルといった哺乳類由来の細胞や、昆虫由来の細胞であってもよい。さらに継代数の異なる同種細胞であってもよい。 The types of cells (hereinafter sometimes referred to as "cell types") are not particularly limited as long as they are two or more types, and may be three or more types. There is no particular limit to the combination of cell types used, but fibroblasts and/or epithelial cells are preferably used in the present invention. In addition, the present invention can be used for a state in which different types of cells, such as blood cells and cells that construct the nervous system or visceral system, are mixed, or for a state in which cells with differentiation ability, such as mesenchymal stem cells, are in different differentiation states, but adhesive cells are preferable. In addition, the cells may be non-human cells, such as cells derived from mammals such as mice, hamsters, rabbits, and monkeys, or cells derived from insects. Furthermore, the cells may be allogeneic cells with different passage numbers.
培地は特に限定はなく、イーグル最小必須培地(MEM)などの基礎培地にウシ胎児血清等の血清や抗生物質などが添加された培地を用いてもよいし、細胞外マトリックスが添加された無血清培地を用いてもよい。培地中の血清濃度や細胞外マトリックス濃度は特に限定はなく、各々の細胞種で細胞分離に適した濃度を用いればよい。例えば、牛胎児由来血清の濃度であれば1~30vol%が好ましく、5~20vol%がより好ましい。 There are no particular limitations on the medium, and a medium in which serum such as fetal bovine serum or antibiotics have been added to a basal medium such as Eagle's minimum essential medium (MEM) may be used, or a serum-free medium to which an extracellular matrix has been added may be used. There are no particular limitations on the serum concentration or extracellular matrix concentration in the medium, and a concentration suitable for cell separation for each cell type may be used. For example, the concentration of fetal bovine serum is preferably 1 to 30 vol%, and more preferably 5 to 20 vol%.
本発明の細胞分離方法は、上述したブロック共重合体を被覆した細胞培養器材に2種類以上の細胞を播種する工程(以下、「播種工程」ということがある)と、前記細胞培養器材から前記ブロック共重合体に非接着の細胞を除く工程(以下、「除去工程」ということがある)と、前記細胞培養器材をLCST以下に冷却して前記ブロック共重合体に接着した細胞を回収する工程(以下、「回収工程」ということがある)と、を含んでなる。 The cell separation method of the present invention includes a step of seeding two or more types of cells onto a cell culture substrate coated with the above-mentioned block copolymer (hereinafter, sometimes referred to as the "seeding step"); a step of removing cells that are not adhered to the block copolymer from the cell culture substrate (hereinafter, sometimes referred to as the "removal step"); and a step of cooling the cell culture substrate to below the LCST and recovering the cells that have adhered to the block copolymer (hereinafter, sometimes referred to as the "recovery step").
播種工程では、一部の細胞種が接着しない又は接着率が低くなるよう、ブロック共重合体の被覆量、培地中の血清濃度、培養時間の調整などを一つ又は組み合わせて行う。ただし、培養時間に関しては、30分間~12時間とすることが好ましく、1時間から3時間がより好ましい。 In the seeding process, the amount of block copolymer coated, the serum concentration in the medium, and the culture time are adjusted, either alone or in combination, so that some cell types do not adhere or have a low adhesion rate. However, the culture time is preferably 30 minutes to 12 hours, and more preferably 1 hour to 3 hours.
除去工程では、非接着の細胞を、例えばピペッターを用いて培地ごと回収する方法が例示できる。非接着の細胞除去後はLCST以上から42℃以下のPBS又は培地(血清を含んでいても良い)を先述の細胞培養器材に加えて洗浄してもよい。 In the removal step, the non-adherent cells may be collected together with the medium using, for example, a pipetter. After removing the non-adherent cells, the cell culture equipment may be washed by adding PBS or medium (which may contain serum) at a temperature between the LCST and 42°C.
回収工程では、ブロック共重合体に残存した細胞を回収する。冷却する方法は特に限定はなく、冷所で冷却しても良いし、冷却した培地で培地交換することで冷却しても良い。冷却する温度はLCST以下の温度であれば特に限定はないが、残存した細胞の回収を促すため、LCSTより2℃以上低い温度が好ましく、LCSTより4℃以上低い温度がより好ましい。冷却時間は、40分未満が好ましく、20分未満がより好ましく、10分未満がさらに好ましい。冷却後は細胞培養器材から剥離した細胞を回収することができるが、細胞培養器材からの剥離が不完全な場合は、ピペッティングやタッピング、振とうなどの物理的衝撃を加えてもよい。 In the recovery step, the cells remaining in the block copolymer are recovered. There is no particular limitation on the cooling method, and the cells may be cooled in a cold place or by replacing the medium with a cooled medium. There is no particular limitation on the cooling temperature as long as it is below the LCST, but in order to promote recovery of the remaining cells, a temperature that is at least 2°C lower than the LCST is preferred, and a temperature that is at least 4°C lower than the LCST is more preferred. The cooling time is preferably less than 40 minutes, more preferably less than 20 minutes, and even more preferably less than 10 minutes. After cooling, the cells detached from the cell culture equipment can be recovered, but if detachment from the cell culture equipment is incomplete, physical impact such as pipetting, tapping, or shaking may be applied.
回収工程で回収した細胞は、さらに本発明の細胞分離方法を繰り返すことで、さらに細胞を分離・精製することができる。二回目の細胞分離を行う際は、一回目の細胞分離の際よりもブロック共重合体のLCSTを示すセグメントの被覆量を同量以上とした細胞培養器材を用いることが好ましい。三回目の細胞分離を行う際は、二回目の細胞分離の際よりもブロック共重合体のLCSTを示すセグメントの被覆量を同量以上とすることが好ましい。例えば3種類の細胞a、b、c(ブロック共重合体への接着性 c>b>a)を培養する場合において、一回目の操作で非接着細胞aを分離し、冷却処理でb及びcの混合物を回収できる。さらに二回目の操作でブロック共重合体のLCSTを示すセグメントの被覆量を上げた細胞培養器材を用いることで、非接着細胞bを分離し、冷却処理でcの混合物を回収できる。 The cells recovered in the recovery step can be further separated and purified by repeating the cell separation method of the present invention. When performing the second cell separation, it is preferable to use a cell culture vessel in which the amount of the segment showing the LCST of the block copolymer coated is equal to or greater than that in the first cell separation. When performing the third cell separation, it is preferable to use the amount of the segment showing the LCST of the block copolymer coated is equal to or greater than that in the second cell separation. For example, when culturing three types of cells a, b, and c (adhesiveness to block copolymer c>b>a), the non-adhesive cell a can be separated in the first operation, and a mixture of b and c can be recovered by cooling treatment. Furthermore, by using a cell culture vessel in which the amount of the segment showing the LCST of the block copolymer coated is increased in the second operation, the non-adhesive cell b can be separated, and a mixture of c can be recovered by cooling treatment.
以下に本発明の実施例を説明するが、本発明はこれら実施例により何ら制限されるものではない。なお、断りのない限り、試薬は市販品を用いた。 The following examples of the present invention are provided, but the present invention is not limited to these examples. Unless otherwise noted, commercially available reagents were used.
<ブロック共重合体の合成>
100mL2口フラスコに2-メトキシエチルアクリレート(MEA,HLB値=13.5)0.650g(5mmol)を加え、さらにシアノメチルドデシルカルボナトを31.8mg(100μmol)とアゾビスイソブチロニトリル1.6mg(10μmol)と1,4-ジオキサン10mLを加え、アルゴンガス置換後、62℃で24時間加熱撹拌した。
1回目の加熱撹拌後、上記にn-ブチルアクリレート(BA,HLB値=6.9)3.845g(30mmol)を加え、さらにアゾビスイソブチロニトリル1.6mg(10μmol)と1,4-ジオキサン5mLを加え、アルゴンガス置換後、62℃で48時間加熱撹拌した。
2回目の加熱撹拌後、上記にN-イソプロピルアクリルアミド(IPAAm,LCST=32℃、HLB値=7.6)7.355g(65mmol)を加え、さらにアゾビスイソブチロニトリル1.6mg(10μmol)と1,4-ジオキサン35mLを加え、アルゴンガス置換後、62℃で48時間加熱撹拌した。
3回目の加熱撹拌後、反応液を水で再沈精製し、減圧乾燥することで黄色固体を得た。
得られた黄色固体をクロロホルムに溶解し、分液ロートを用いクロロホルム相を回収した。回収したクロロホルム相をエバポレーターで濃縮し、ヘキサンで再沈精製した。沈殿物をろ過で回収し、減圧乾燥することで、ブロック共重合体poly(MEA-BA-IPAAm)を5.805g得た。得られたブロック共重合体の組成比はMEA/BA/IPAAm=5/26/69(mol%)であり、数平均分子量Mnは8.5万、分子量分布Mw/Mnは1.78であった。
<Synthesis of block copolymer>
To a 100 mL two-neck flask, 0.650 g (5 mmol) of 2-methoxyethyl acrylate (MEA, HLB value = 13.5) was added, and 31.8 mg (100 μmol) of cyanomethyl dodecyl carbonate, 1.6 mg (10 μmol) of azobisisobutyronitrile, and 10 mL of 1,4-dioxane were further added. After replacing with argon gas, the mixture was heated and stirred at 62°C for 24 hours.
After the first heating and stirring, 3.845 g (30 mmol) of n-butyl acrylate (BA, HLB value = 6.9) was added to the above, and 1.6 mg (10 μmol) of azobisisobutyronitrile and 5 mL of 1,4-dioxane were further added. After replacing with argon gas, the mixture was heated and stirred at 62°C for 48 hours.
After the second heating and stirring, 7.355 g (65 mmol) of N-isopropylacrylamide (IPAAm, LCST = 32°C, HLB value = 7.6) was added to the above, and 1.6 mg (10 µmol) of azobisisobutyronitrile and 35 mL of 1,4-dioxane were further added. After replacing with argon gas, the mixture was heated and stirred at 62°C for 48 hours.
After the third heating and stirring, the reaction liquid was purified by reprecipitation with water and dried under reduced pressure to obtain a yellow solid.
The obtained yellow solid was dissolved in chloroform, and the chloroform phase was collected using a separatory funnel. The collected chloroform phase was concentrated using an evaporator and purified by reprecipitation with hexane. The precipitate was collected by filtration and dried under reduced pressure to obtain 5.805 g of a block copolymer poly(MEA-BA-IPAAm). The composition ratio of the obtained block copolymer was MEA/BA/IPAAm=5/26/69 (mol%), the number average molecular weight Mn was 85,000, and the molecular weight distribution Mw/Mn was 1.78.
<ブロック共重合体の組成>
核磁気共鳴測定装置(日本電子製、商品名JNM-ECZ400S/L1)を用いたプロトン核磁気共鳴分光(1H-NMR)スペクトル分析より求めた。
<ブロック共重合体の分子量、分子量分布>
重量平均分子量(Mw)、数平均分子量(Mn)及び分子量分布(Mw/Mn)は、ゲル・パーミエーション・クロマトグラフィー(GPC)によって測定した。GPC装置は東ソー(株)製 HLC-8320GPCを用い、カラムは東ソー製 TSKgel SuperAWM-Hを2本用い、カラム温度を40℃に設定し、溶離液は10mMトリフルオロ酢酸ナトリウムを含む2,2,2-トリフルオロエタノールを用いて測定した。測定試料は1.0mg/mLで調製して測定した。分子量の検量線は、分子量既知のポリメタクリル酸メチル(Sigma-Aldrich社製)を用いた。
<細胞培養器材のLCSTを示すセグメントの被覆量>
ブロック共重合体を被覆した細胞培養器材のLCSTを示すセグメント(IPAAm)の被覆量はIPAAmセグメントの被覆量を全反射型フーリエ変換型赤外分光(ATR/FT-IR)法により解析した。解析には被覆量が既知のサンプルから作成した検量線を用い、単位面積当たりのLCSTを示すセグメントの被覆量(μg/cm2)で評価した。
<Composition of block copolymer>
The amount was determined by proton nuclear magnetic resonance spectroscopy (1H-NMR) spectrum analysis using a nuclear magnetic resonance measurement device (manufactured by JEOL Ltd., trade name JNM-ECZ400S/L1).
<Molecular weight and molecular weight distribution of block copolymer>
Weight average molecular weight (Mw), number average molecular weight (Mn) and molecular weight distribution (Mw/Mn) were measured by gel permeation chromatography (GPC). The GPC apparatus used was a Tosoh Corporation HLC-8320GPC, and two Tosoh Corporation TSKgel SuperAWM-H columns were used. The column temperature was set to 40°C, and the eluent was 2,2,2-trifluoroethanol containing 10 mM sodium trifluoroacetate. The measurement sample was prepared at 1.0 mg/mL and measured. For the molecular weight calibration curve, polymethylmethacrylate (Sigma-Aldrich) with a known molecular weight was used.
<Coating amount of segment showing LCST of cell cultureware>
The amount of IPAAm segments (IPAAm) showing LCST on the cell cultureware coated with the block copolymer was analyzed by total reflection Fourier transform infrared spectroscopy (ATR/FT-IR). A calibration curve prepared from samples with known amounts of coating was used for the analysis, and the amount of LCST segments per unit area (μg/ cm2 ) was evaluated.
<播種した細胞数の計測>
播種する細胞の数は血球計算盤を用いて計測した。血球計算盤の四隅の1mm2区画内の全細胞を数え、全細胞数を(区画中の全生細胞の平均値)×希釈倍率×培地量(mL)×10000で算出した。
<細胞種の割合解析>
予め、細胞の種類ごとに、色素の異なるCellTrackerTM(Themofisher Scientific社製)を用い、細胞を染色した。混合済みの染色した細胞の懸濁液を細胞培養器材に播種し、37℃、5%CO2条件で所定の時間培養後、非接着の細胞を培地ごと除去した後の培養器材上の残存細胞を、対物レンズ10倍の共焦点定量イメージサイトメーターCQ1(横河電機社製)を用い画像撮影を行った。画像解析はImageJを用い、一例として、CellTrackerTM Blue CMACで染色した細胞は色相124~255、CellTrackerTM Green CMFDAで染色した細胞は色相60~100、CellTrackerTM Orange CMTMRで染色した細胞は色相0~30で各細胞の面積を割り出し、細胞当たりの染色面積で割ることで、細胞種の割合を解析した。
<Counting the number of seeded cells>
The number of cells to be seeded was measured using a hemocytometer. All cells in 1 mm2 sections at the four corners of the hemocytometer were counted, and the total cell number was calculated by (average number of all live cells in the section) x dilution factor x medium volume (mL) x 10,000.
<Cell type ratio analysis>
The cells were stained in advance using CellTracker ™ (manufactured by Thermofisher Scientific) with different dyes for each type of cell. The mixed suspension of stained cells was seeded on a cell culture vessel, and after culturing for a predetermined time under conditions of 37°C and 5% CO2 , non-adherent cells were removed together with the medium, and the remaining cells on the culture vessel were imaged using a confocal quantitative image cytometer CQ1 (manufactured by Yokogawa Electric Corporation) with a 10x objective lens. Image analysis was performed using ImageJ. As an example, the area of each cell was calculated using a hue of 124 to 255 for cells stained with CellTracker ™ Blue CMAC, a hue of 60 to 100 for cells stained with CellTracker ™ Green CMFDA, and a hue of 0 to 30 for cells stained with CellTracker ™ Orange CMTMR, and the proportion of cell types was analyzed by dividing the area by the stained area per cell.
実施例1
2.0wt%のブロック共重合体の2-メトキシエタノール溶液を調製した。IWAKI組織培養用ディッシュ(φ6cm)の中央にブロック共重合体/2-メトキシエタノール溶液を100μL加え、スピンコータ―(ミカサ社製、商品名MS-B200)を用いて、回転数2,000rpm、回転時間60秒の条件でスピンコートすることで、ブロック共重合体を被覆した細胞培養器材(1)を調製した。器材培養面のIPAAmセグメントの被覆量は5.8μg/cm2であった。
調製した細胞培養器材(1)を用いてTIG3-20細胞(CellTrackerTM blue CMACで染色済み)とA549細胞(CellTrackerTM Green CMFDAで染色済み)とPC9細胞(CellTrackerTM ORANGE CMTMR)を1×105個ずつ含む細胞懸濁液を播種した。培地はD-MEM基礎培地にウシ胎児血清10%と抗生物質を加えたものを用い、37℃、5%CO2条件で1時間共培養した。ブロック共重合体に非接着の細胞を培地ごと除去した。非接着細胞除去後の残存細胞の割合を表1に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行うことで細胞が剥がれ、PC9細胞の比率が75.7%の細胞懸濁液を回収できた。
Example 1
A 2.0 wt% solution of the block copolymer in 2-methoxyethanol was prepared. 100 μL of the block copolymer/2-methoxyethanol solution was added to the center of an IWAKI tissue culture dish (φ6 cm), and spin-coated using a spin coater (manufactured by Mikasa, product name MS-B200) at a rotation speed of 2,000 rpm for a rotation time of 60 seconds to prepare a cell culture substrate (1) coated with the block copolymer. The coating amount of the IPAAm segment on the substrate culture surface was 5.8 μg/ cm2 .
Using the prepared cell cultureware (1), a cell suspension containing 1x105 cells each of TIG3-20 cells (stained with CellTracker ™ blue CMAC), A549 cells (stained with CellTracker ™ Green CMFDA), and PC9 cells (CellTracker ™ Orange CMTMR) was seeded. The medium used was D-MEM basal medium supplemented with 10% fetal bovine serum and antibiotics, and the cells were co-cultured for 1 hour at 37°C and 5% CO2 . The cells that did not adhere to the block copolymer were removed together with the medium. The percentage of remaining cells after removing non-adherent cells is shown in Table 1. The medium cooled to 4°C was added to the cell cultureware containing the remaining cells, and the cells were detached by pipetting after leaving it for 10 minutes, and a cell suspension containing 75.7% PC9 cells was recovered.
実施例2
4.0wt%のブロック共重合体の2-メトキシエタノール溶液を用いたことは実施例1記載の方法でブロック共重合体を被覆した細胞培養器材(2)を調製した。器材培養面のIPAAmセグメントの被覆量は13.3μg/cm2であった。
細胞培養器材(2)を用いたこと以外は実施例1と同様の方法で培養した。非接着細胞除去後の残存細胞の割合を表1に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行うことで細胞が剥がれ、PC9細胞の比率が89.4%の細胞懸濁液を回収できた。
Example 2
A 4.0 wt % 2-methoxyethanol solution of the block copolymer was used to prepare a cell culture substrate (2) coated with the block copolymer by the method described in Example 1. The coating amount of the IPAAm segment on the substrate culture surface was 13.3 μg/ cm2 .
Culturing was performed in the same manner as in Example 1, except that the cell culture equipment (2) was used. The percentage of remaining cells after removing non-adherent cells is shown in Table 1. The medium cooled to 4°C was added to the cell culture equipment containing the remaining cells, and after leaving it for 10 minutes, the cells were detached by pipetting, and a cell suspension containing 89.4% PC9 cells was recovered.
比較例1
細胞培養器材としてIWAKI組織培養用ディッシュ(φ6cm)を用いたこと以外は、実施例1と同様の方法で培養した。非接着細胞除去後の残存細胞率を表1に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行ったが、細胞が剥がれなかった。
Comparative Example 1
Except for using an IWAKI tissue culture dish (φ6 cm) as the cell culture equipment, the culture was performed in the same manner as in Example 1. The remaining cell rate after removing non-adherent cells is shown in Table 1. The medium cooled to 4°C was added to the cell culture equipment containing the remaining cells, and pipetting was performed after leaving it for 10 minutes, but the cells did not detach.
比較例2
細胞培養器材としてセルシード社製UpCellR(φ6cm)を用いたこと以外は、実施例1と同様の方法で培養した。非接着細胞除去後の残存細胞率を表1に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行うことで細胞が剥がれたが、細胞分離されていない細胞懸濁液の回収となった。
Comparative Example 2
Cultivation was performed in the same manner as in Example 1, except that UpCell® (φ6 cm) manufactured by CellSeed was used as the cell cultureware. The remaining cell rate after removing non-adherent cells is shown in Table 1. The cells were detached by adding medium cooled to 4°C to the cell cultureware containing the remaining cells and leaving it for 10 minutes and then pipetting, but the collected cell suspension was not cell-separated.
実施例3
細胞培養器材(1)を用いて、実施例1と同様の方法で培養した。非接着細胞除去後の残存細胞の割合を表2に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行うことで、PC9細胞の比率が76.3%の細胞懸濁液を回収した。
回収したPC9細胞の比率が高い細胞懸濁液を細胞培養器材(2)に播種した。培地はD-MEM基礎培地にウシ胎児血清10%と抗生物質を加えたものを用い、37℃、5%CO2条件で1時間共培養した。ブロック共重合体に非接着の細胞を培地ごと除去した。
非接着細胞除去後の残存細胞率を表2に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行うことで、PC9細胞の比率が95.0%の細胞懸濁液を回収できた。
Example 3
Using the cell culture equipment (1), culture was performed in the same manner as in Example 1. The percentage of remaining cells after removing non-adherent cells is shown in Table 2. A medium cooled to 4°C was added to the cell culture equipment containing the remaining cells, and after leaving it for 10 minutes, pipetting was performed to recover a cell suspension containing 76.3% PC9 cells.
The cell suspension containing a high ratio of collected PC9 cells was seeded on cell culture equipment (2). The medium used was D-MEM basal medium supplemented with 10% fetal bovine serum and antibiotics, and the cells were co-cultured for 1 hour at 37°C and 5% CO2 . Cells that did not adhere to the block copolymer were removed together with the medium.
The remaining cell ratio after removal of non-adherent cells is shown in Table 2. A cell suspension containing 95.0% PC9 cells was recovered by adding medium cooled to 4°C to the cell culture equipment containing the remaining cells and leaving it for 10 minutes, followed by pipetting.
実施例4
0.4wt%のブロック共重合体の2-メトキシエタノール溶液を調製した。IWAKI組織培養用ディッシュ(φ6cm)の中央にブロック共重合体/2-メトキシエタノール溶液を100μL加え、スピンコータ―(ミカサ社製、商品名MS-B200)を用いて、回転数2,000rpm、回転時間60秒の条件でスピンコートすることで、ブロック共重合体を被覆した細胞培養器材(3)を調製した。器材培養面のIPAAmセグメントの被覆量は0.5μg/cm2であった。
調製した細胞培養器材(3)を用いてヒト骨髄由来間葉系幹細胞(CellTrackerTM ORANGE CMTMRで染色済み)とRAMOS細胞(CellTrackerTM Green CMFDAで染色済み)を1×105個ずつ含む細胞懸濁液を播種した。培地はD-MEM基礎培地にウシ胎児血清10%と抗生物質を加えたものを用い、37℃、5%CO2条件で1時間共培養した。ブロック共重合体に非接着の細胞を培地ごと除去した。非接着細胞除去後の残存細胞の割合を表3に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行うことで細胞が剥がれ、ヒト骨髄由来間葉系幹細胞の比率が99.0%の細胞懸濁液を回収できた。
Example 4
A 0.4 wt% solution of the block copolymer in 2-methoxyethanol was prepared. 100 μL of the block copolymer/2-methoxyethanol solution was added to the center of an IWAKI tissue culture dish (φ6 cm), and spin-coated using a spin coater (manufactured by Mikasa, product name MS-B200) at a rotation speed of 2,000 rpm for a rotation time of 60 seconds to prepare a cell culture substrate (3) coated with the block copolymer. The coating amount of the IPAAm segment on the substrate culture surface was 0.5 μg/ cm2 .
Using the prepared cell cultureware (3), a cell suspension containing 1 x 105 human bone marrow-derived mesenchymal stem cells (stained with CellTracker ™ Orange CMTMR) and RAMOS cells (stained with CellTracker ™ Green CMFDA) was seeded. The medium used was D-MEM basal medium supplemented with 10% fetal bovine serum and antibiotics, and the cells were co-cultured for 1 hour at 37°C and 5% CO2 . The cells that did not adhere to the block copolymer were removed together with the medium. The percentage of remaining cells after removing non-adherent cells is shown in Table 3. The medium cooled to 4°C was added to the cell cultureware containing the remaining cells, and the cells were detached by pipetting after leaving it for 10 minutes, and a cell suspension containing 99.0% human bone marrow-derived mesenchymal stem cells was recovered.
実施例5
1.5wt%のブロック共重合体の2-メトキシエタノール溶液を調製した。IWAKI組織培養用ディッシュ(φ6cm)の中央にブロック共重合体/2-メトキシエタノール溶液を100μL加え、スピンコータ―(ミカサ社製、商品名MS-B200)を用いて、回転数2,000rpm、回転時間60秒の条件でスピンコートすることで、ブロック共重合体を被覆した細胞培養器材(4)を調製した。器材培養面のIPAAmセグメントの被覆量は4.0μg/cm2であった。
調製した細胞培養器材(4)を用いてヒト歯髄由来間葉系幹細胞(CellTrackerTM ORANGE CMTMRで染色済み)とヒト脂肪由来間葉系幹細胞(CellTrackerTM Green CMFDAで染色済み)を1×105個ずつ含む細胞懸濁液を播種した。培地はD-MEM基礎培地にウシ胎児血清10%と抗生物質を加えたものを用い、37℃、5%CO2条件で1時間共培養した。ブロック共重合体に非接着の細胞を培地ごと除去した。非接着細胞除去後の残存細胞の割合を表4に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行うことで細胞が剥がれ、ヒト脂肪由来間葉系幹細胞の比率が85.2%の細胞懸濁液を回収できた。
Example 5
A 1.5 wt% solution of the block copolymer in 2-methoxyethanol was prepared. 100 μL of the block copolymer/2-methoxyethanol solution was added to the center of an IWAKI tissue culture dish (φ6 cm), and spin-coated using a spin coater (manufactured by Mikasa, product name MS-B200) at a rotation speed of 2,000 rpm for a rotation time of 60 seconds to prepare a cell culture substrate (4) coated with the block copolymer. The coating amount of the IPAAm segment on the substrate culture surface was 4.0 μg/ cm2 .
Using the prepared cell cultureware (4), a cell suspension containing 1 x 105 cells of human dental pulp-derived mesenchymal stem cells (stained with CellTracker ™ Orange CMTMR) and human adipose-derived mesenchymal stem cells (stained with CellTracker ™ Green CFDA) was seeded. The medium used was a D-MEM basal medium supplemented with 10% fetal bovine serum and antibiotics, and the cells were co-cultured for 1 hour at 37°C and 5 % CO2 . The cells that did not adhere to the block copolymer were removed together with the medium. The percentage of remaining cells after removing non-adherent cells is shown in Table 4. The medium cooled to 4°C was added to the cell cultureware containing the remaining cells, and the cells were peeled off by pipetting after leaving it for 10 minutes, and a cell suspension containing 85.2% human adipose-derived mesenchymal stem cells was recovered.
実施例6
2.5wt%のブロック共重合体の2-メトキシエタノール溶液を調製した。IWAKI組織培養用ディッシュ(φ6cm)の中央にブロック共重合体/2-メトキシエタノール溶液を100μL加え、スピンコータ―(ミカサ社製、商品名MS-B200)を用いて、回転数2,000rpm、回転時間60秒の条件でスピンコートすることで、ブロック共重合体を被覆した細胞培養器材(5)を調製した。器材培養面のIPAAmセグメントの被覆量は6.9μg/cm2であった。
調製した細胞培養器材(5)を用いてヒト肝癌由来細胞HepG2(CellTrackerTM ORANGE CMTMRで染色済み)とヒト結腸腺癌細胞HCT116(CellTrackerTM Green CMFDAで染色済み)を1×105個ずつ含む細胞懸濁液を播種した。培地はD-MEM基礎培地にウシ胎児血清10%と抗生物質を加えたものを用い、37℃、5%CO2条件で1時間共培養した。ブロック共重合体に非接着の細胞を培地ごと除去した。非接着細胞除去後の残存細胞の割合を表5に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行うことで細胞が剥がれ、ヒト結腸腺癌細胞HCT116の比率が98.1%の細胞懸濁液を回収できた。
Example 6
A 2.5 wt% solution of the block copolymer in 2-methoxyethanol was prepared. 100 μL of the block copolymer/2-methoxyethanol solution was added to the center of an IWAKI tissue culture dish (φ6 cm), and spin-coated using a spin coater (manufactured by Mikasa, product name MS-B200) at a rotation speed of 2,000 rpm for a rotation time of 60 seconds to prepare a cell culture substrate (5) coated with the block copolymer. The coating amount of the IPAAm segment on the substrate culture surface was 6.9 μg/ cm2 .
Using the prepared cell cultureware (5), a cell suspension containing 1 x 105 cells each of human hepatoma-derived cells HepG2 (stained with CellTracker ™ ORANGE CMTMR) and human colon adenocarcinoma cells HCT116 (stained with CellTracker ™ Green CMFDA) was seeded. The medium used was D-MEM basal medium supplemented with 10% fetal bovine serum and antibiotics, and the cells were co-cultured for 1 hour at 37°C and 5% CO2 . The cells that did not adhere to the block copolymer were removed together with the medium. The percentage of remaining cells after removing non-adherent cells is shown in Table 5. The medium cooled to 4°C was added to the cell cultureware containing the remaining cells, and the cells were detached by pipetting after leaving it for 10 minutes, and a cell suspension containing 98.1% human colon adenocarcinoma cells HCT116 was recovered.
実施例7
1.0wt%のブロック共重合体の2-メトキシエタノール溶液を調製した。IWAKI組織培養用ディッシュ(φ6cm)の中央にブロック共重合体/2-メトキシエタノール溶液を100μL加え、スピンコータ―(ミカサ社製、商品名MS-B200)を用いて、回転数2,000rpm、回転時間60秒の条件でスピンコートすることで、ブロック共重合体を被覆した細胞培養器材(6)を調製した。器材培養面のIPAAmセグメントの被覆量は2.6μg/cm2であった。
調製した細胞培養器材(6)を用いてTIG3-20細胞(CellTrackerTM ORANGE CMTMRで染色済み)とTIG3-60細胞(CellTrackerTM Green CMFDAで染色済み)を1×105個ずつ含む細胞懸濁液を播種した。培地はD-MEM基礎培地にウシ胎児血清10%と抗生物質を加えたものを用い、37℃、5%CO2条件で1時間共培養した。ブロック共重合体に非接着の細胞を培地ごと除去した。非接着細胞除去後の残存細胞の割合を表6に示す。残存細胞を含む細胞培養器材へ4℃に冷却した培地を加え、10分放置後にピペッティングを行うことで細胞が剥がれ、TIG3-20細胞の比率が83.3%の細胞懸濁液を回収できた。
Example 7
A 1.0 wt% solution of the block copolymer in 2-methoxyethanol was prepared. 100 μL of the block copolymer/2-methoxyethanol solution was added to the center of an IWAKI tissue culture dish (φ6 cm), and spin-coated using a spin coater (manufactured by Mikasa, product name MS-B200) at a rotation speed of 2,000 rpm for a rotation time of 60 seconds to prepare a cell culture substrate (6) coated with the block copolymer. The coating amount of the IPAAm segment on the substrate culture surface was 2.6 μg/ cm2 .
Using the prepared cell cultureware (6), a cell suspension containing 1 x 105 TIG3-20 cells (stained with CellTracker ™ Orange CMTMR) and TIG3-60 cells (stained with CellTracker ™ Green CMFDA) was seeded. The medium used was a D-MEM basal medium supplemented with 10% fetal bovine serum and antibiotics, and the cells were co-cultured for 1 hour at 37°C and 5% CO2 . The cells that did not adhere to the block copolymer were removed together with the medium. The percentage of remaining cells after removing non-adherent cells is shown in Table 6. The medium cooled to 4°C was added to the cell cultureware containing the remaining cells, and the cells were detached by pipetting after leaving it for 10 minutes, and a cell suspension containing 83.3% TIG3-20 cells was recovered.
Claims (3)
前記細胞培養器材から前記ブロック共重合体に非接着の細胞を除く工程と、
前記細胞培養器材を下限臨界溶解温度(LCST)以下に冷却して前記ブロック共重合体に接着した細胞を回収する工程と、
を含んでなることを特徴とする細胞分離方法であって、
播種する細胞が、TIG3-20細胞、TIG3-60細胞、A549細胞、PC9細胞、ヒト骨髄由来間葉系幹細胞、ヒト歯髄由来間葉系幹細胞、ヒト脂肪由来間葉系幹細胞、ヒト肝癌由来細胞及び/又はヒト結腸腺癌細胞であって、
前記N-イソプロピルアクリルアミドの被覆量が0.1~20.0μg/cm2である方法。 A step of seeding two or more types of cells onto a cell culture vessel coated with only a block copolymer containing repeating units of 2-methoxyethyl acrylate, n-butyl acrylate, and N-isopropylacrylamide ;
removing cells that are not adhered to the block copolymer from the cell culture substrate;
a step of cooling the cell culture substrate to a lower critical solution temperature ( LCST ) or lower to recover the cells adhered to the block copolymer;
A cell separation method comprising:
The cells to be seeded are TIG3-20 cells, TIG3-60 cells, A549 cells, PC9 cells, human bone marrow-derived mesenchymal stem cells, human dental pulp-derived mesenchymal stem cells, human adipose-derived mesenchymal stem cells, human hepatoma-derived cells, and/or human colon adenocarcinoma cells ,
The coating amount of the N-isopropylacrylamide is 0.1 to 20.0 μg/ cm2 .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019080779 | 2019-04-22 | ||
JP2019080779 | 2019-04-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020174660A JP2020174660A (en) | 2020-10-29 |
JP7480485B2 true JP7480485B2 (en) | 2024-05-10 |
Family
ID=72936236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019181181A Active JP7480485B2 (en) | 2019-04-22 | 2019-10-01 | Cell Isolation Methods |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7480485B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022202911A1 (en) * | 2021-03-26 | 2022-09-29 | 東ソー株式会社 | Temperature-responsive polymer surface treatment agent |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005295969A (en) | 2004-04-16 | 2005-10-27 | Hitachi Medical Corp | Cellular segregation device |
JP2006223195A (en) | 2005-02-17 | 2006-08-31 | National Institute Of Advanced Industrial & Technology | Adsorbing material for cell separation, adsorbing material module for cell separation and method for separating cell |
JP2016131561A (en) | 2015-01-22 | 2016-07-25 | 国立大学法人山形大学 | Method of recovering cells, and polymer used for the same |
JP2018087316A (en) | 2016-08-03 | 2018-06-07 | 東ソー株式会社 | Block copolymer and surface treatment agent using same |
-
2019
- 2019-10-01 JP JP2019181181A patent/JP7480485B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005295969A (en) | 2004-04-16 | 2005-10-27 | Hitachi Medical Corp | Cellular segregation device |
JP2006223195A (en) | 2005-02-17 | 2006-08-31 | National Institute Of Advanced Industrial & Technology | Adsorbing material for cell separation, adsorbing material module for cell separation and method for separating cell |
JP2016131561A (en) | 2015-01-22 | 2016-07-25 | 国立大学法人山形大学 | Method of recovering cells, and polymer used for the same |
JP2018087316A (en) | 2016-08-03 | 2018-06-07 | 東ソー株式会社 | Block copolymer and surface treatment agent using same |
Also Published As
Publication number | Publication date |
---|---|
JP2020174660A (en) | 2020-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6638706B2 (en) | Block copolymer and surface treatment agent using the same | |
US11441120B2 (en) | Cell culture substrate | |
TWI720333B (en) | Preparation method of pluripotent stem cell, preparation method of pluripotent stem cell using the preparation method, ameliorating agent, and differentiation induction method of the pluripotent stem cell | |
JP2016192957A (en) | Cell culture substrate, method for producing the same, and cell culture method using the same | |
JP7127330B2 (en) | Block copolymer and surface treatment agent using the same | |
Loh et al. | Novel poly (N-isopropylacrylamide)-poly [(R)-3-hydroxybutyrate]-poly (N-isopropylacrylamide) triblock copolymer surface as a culture substrate for human mesenchymal stem cells | |
JP6497677B2 (en) | Block copolymer, surface treatment agent, membrane thereof, and cell culture substrate coated with the same | |
Nagase et al. | Thermoresponsive anionic copolymer brush-grafted surfaces for cell separation | |
US10131874B2 (en) | Cell culture support and associated method for cell growth and release | |
EP2949743A1 (en) | Stimulation-responsive material and cell culture container made thereof | |
US20130171729A1 (en) | Methods and kits for cell release | |
US20210355424A1 (en) | Cell culture substrate, method for producing cell culture substrate, and method for producing spheroids | |
JP7480485B2 (en) | Cell Isolation Methods | |
Dabiri et al. | Multifunctional thermoresponsive microcarriers for high‐throughput cell culture and enzyme‐free cell harvesting | |
Darge et al. | Preparation of thermosensitive PNIPAm‐based copolymer coated cytodex 3 microcarriers for efficient nonenzymatic cell harvesting during 3D culturing | |
US11427803B2 (en) | Cell culture substrate | |
JP2020110140A (en) | Cell culture method | |
JP7250248B2 (en) | BLOCK COPOLYMER, SURFACE TREATMENT AGENT AND MEMBRANE CONTAINING THE SAME, AND CELL CULTURE EQUIPMENT AND CELL CULTURE METHOD USING THE SAME | |
WO2019035436A1 (en) | Culture substrate for pluripotent stem cell and method for producing pluripotent stem cell | |
Yang et al. | In vitro study of the interactions of galactosylated thermo-responsive hydrogels with cells | |
Matsuda et al. | Cell sorting technique based on thermoresponsive differential cell adhesiveness | |
JP7271870B2 (en) | Substrate for culture of pluripotent stem cells and method for producing pluripotent stem cells | |
JP7293683B2 (en) | Block copolymer, culture substrate, and method for producing stem cells | |
JP2021151210A (en) | Microcarrier, and culture method of cell using the same | |
JP2022105806A (en) | Method for culturing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220915 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230821 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230905 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231018 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20231212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231226 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20240104 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240326 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240408 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7480485 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |